Clinical Trial Update: Efficacy of All-Oral Anti-Viral Therapy for Symptomatic Hepatitis C Virus Infection-Related Cryoglobulinemia [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial update on an all-oral antiviral therapy for symptomatic hepatitis C virus–related cryoglobulinemia; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cryoglobulinemia
• Hepatitis C

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Hepatitis C, Cryoglobulinemia | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2020-12-17